Introduction to HHS AI Initiative
The U.S. Department of Health and Human Services (HHS) has taken a groundbreaking step toward transforming healthcare delivery through artificial intelligence. On December 23, 2025, HHS issued a comprehensive request for information (RFI) designed to accelerate the adoption and integration of AI technologies in clinical care settings. This initiative represents the federal government’s first major effort to systematically address the regulatory, financial, and developmental challenges associated with implementing AI solutions in healthcare environments.
Overview of the Request for Information
Purpose and Scope of the RFI
The RFI serves as a critical mechanism for gathering diverse perspectives from healthcare stakeholders nationwide. HHS is actively soliciting input from clinicians, technology developers, healthcare administrators, patients, and other parties currently using or planning to implement AI solutions in clinical care. The Department recognizes that successful AI integration requires balancing innovation with patient safety, privacy protection, and healthcare accessibility.
The initiative addresses fundamental questions about how AI can enhance clinical decision-making, improve patient outcomes, and reduce healthcare costs while maintaining public trust in medical technology. HHS aims to develop evidence-based policies that promote responsible AI adoption without stifling innovation or creating unnecessary barriers to implementation.
Key Priority Areas for Stakeholder Input
Three Strategic Focus Areas
HHS has identified three interconnected priority areas that form the foundation of this RFI: regulation, reimbursement, and research and development. Each area presents unique challenges and opportunities for AI integration in healthcare delivery systems.
Regulatory Framework Development
Creating Predictable and Reliable Standards
The regulatory landscape for AI in healthcare remains complex and evolving. HHS seeks comprehensive feedback on how current regulations impact AI utilization in clinical settings and what modifications are necessary to support widespread adoption. The Department is committed to developing regulatory frameworks that are understandable, predictable, and reliable for all stakeholders.
Effective regulation must strike a delicate balance between ensuring patient safety and enabling technological innovation. HHS recognizes that overly restrictive regulations could impede beneficial AI applications, while insufficient oversight might compromise patient welfare. The RFI encourages stakeholders to identify specific regulatory barriers and propose practical solutions that protect patients while fostering innovation.
Payment Model Modernization
Addressing Reimbursement Challenges
Traditional fee-for-service payment models often create obstacles to cost-effective healthcare innovation. HHS acknowledges that current legacy payment systems may inadvertently discourage AI adoption by failing to adequately reimburse AI-enabled services or recognize the value these technologies bring to patient care.
Supporting Sustainable AI Integration
The Department is exploring comprehensive payment reforms that support reasonable and sustainable AI adoption across healthcare settings. HHS seeks stakeholder input on specific payment policy changes that would promote access to and affordability of clinical AI applications. These reforms aim to align financial incentives with quality outcomes and technological advancement, ensuring that payment structures facilitate rather than hinder AI integration.
Research and Development Priorities
Investing in Long-term Innovation
HHS is soliciting perspectives on applied AI research and development initiatives that can create long-term market opportunities and improve health outcomes. The Department recognizes that strategic research investments today will shape healthcare delivery for decades to come.
Research priorities include developing AI applications that address healthcare disparities, enhance diagnostic accuracy, streamline administrative processes, and support clinical decision-making. HHS is particularly interested in identifying high-impact areas where AI research investment could yield significant improvements in patient care quality and healthcare system efficiency.
Critical Questions for Industry Stakeholders
Targeted Information Gathering
The RFI poses specific questions designed to elicit actionable insights from healthcare professionals and technology developers. These questions address:
Implementation Barriers: What obstacles prevent effective AI deployment in clinical care environments? Stakeholders are encouraged to identify technical, regulatory, financial, and cultural barriers that impede AI adoption.
Policy Priority Changes: Which regulatory and payment policy modifications should HHS prioritize to facilitate AI integration while protecting patient interests?
Legal and Implementation Issues: What novel legal challenges arise from AI use in healthcare, and how should these issues be addressed through policy development?
Research Investment Opportunities: Which areas of AI research would generate the most significant improvements in healthcare delivery and patient outcomes?
Timeline and Participation Guidelines
Opportunity for Industry Influence
This RFI represents a unique opportunity for healthcare stakeholders to shape federal policy regarding AI in clinical care. Organizations and individuals who provide thoughtful, evidence-based input can help create more workable and industry-friendly regulatory frameworks.
The comment period remains open until February 23, 2026, giving stakeholders two months to prepare comprehensive responses. Early participation is encouraged, as this initial feedback will inform subsequent policy development and regulatory initiatives.
Strategic Importance for Healthcare’s Future
The HHS initiative signals a significant shift in federal healthcare policy, acknowledging AI’s transformative potential while addressing legitimate concerns about safety, privacy, and accessibility. Stakeholders who engage meaningfully with this RFI can help ensure that resulting policies support innovation while protecting patient welfare and promoting equitable access to AI-enhanced healthcare services.
